Login / Signup

Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung disease.

Heather SharpeSamira D RowlandCharlotte PoolerGiovanni FerraraKerri A JohannsonMeena KalluriIrvin MayersMichael K Stickland
Published in: BMJ open respiratory research (2024)
Further research is needed to facilitate development of specific exertional oxygen criteria for patients with ILD, to create supports for oxygen use and monitoring and to enable providers to tailor therapy to patients. Oxygen therapy education for ILD should address the benefits and risks of oxygen therapy.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • end stage renal disease
  • idiopathic pulmonary fibrosis
  • healthcare
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • risk assessment